Next Article in Journal
bis(2-Phenylpyridinato)-[4,4′-bis(iodoethynyl)-2,2′-bipyridine]-iridium(III) Hexafluorophosphate
Previous Article in Journal
4-Methyl-N-(1-benzyl)-N’-(1-benzylidene)benzenesulfonohydrazide
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Short Note

(Z)-2-(Bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone

1
Department of Applied Chemistry, National Yang Ming Chiao Tung University, 1001 University Road, Hsinchu City 30010, Taiwan
2
Center for Emergent Functional Matter Science, National Yang Ming Chiao Tung University, 1001 University Road, Hsinchu City 30010, Taiwan
3
Department of Chemistry, Chung Yuan Christian University, 200 Zhongbei Road, Taoyuan City 320314, Taiwan
*
Author to whom correspondence should be addressed.
Molbank 2025, 2025(2), M2023; https://doi.org/10.3390/M2023
Submission received: 22 May 2025 / Revised: 10 June 2025 / Accepted: 12 June 2025 / Published: 16 June 2025

Abstract

An attempt to achieve the deprotonative bromination of a 2-methyl-3-formyl-chromenone with tetrabromomethane led to an unexpected bromo-tribromomethylation product. We report the synthesis and characterization of the title compound.

1. Introduction

Brominated heterocycles display a range of bioactivities [1] and serve as versatile intermediates in nucleophilic substitution and catalytic cross-coupling reactions, facilitating the rapid exploration of chemical space [2]. Therefore, incorporating bromo groups into heterocyclic frameworks is pivotal in synthetic and medicinal chemistry [3]. Among numerous approaches, deprotonative bromination has been widely applied to carbonyl-containing heterocycles, wherein an enolizable position is activated by a base and subsequently trapped by an electrophilic bromine source [4]. Common brominating agents include N-bromosuccinimide, molecular bromine, and tetrabromomethane, the latter being less commonly used than the former, yet displaying an unconventional reactivity mode under suitable conditions [5].
In parallel, a tribromomethyl group has attracted growing interest for its role as both a synthetic handle and a property-modulating motif [6]. Notably, tribromomethylated heterocycles are relevant in developing agrochemicals and pharmaceuticals, particularly where metabolic stability or halogen-bonding interactions are desired. Furthermore, the CBr₃ group serves as a masked functionality that can be transformed into carbonyl derivatives [7], making it strategically valuable for the planning of multistep synthesis. Bromoform or tetrabromomethane is commonly employed for the transfer of tribromomethyl.
Despite the aforementioned features of bromo and tribromomethyl groups, the bromo-tribromomethylation reaction, wherein both a bromine atom and a tribromomethyl group are incorporated into the substrate, has been sporadically reported in the literature [8]. The methodology could be advantageous in synthesizing densely brominated compounds. Herein, we describe our observation of a bromotribromomethylation product obtained from the attempted deprotonative bromination of a 2-methyl-3-formyl-chromenone using tetrabromomethane. The synthesis and structural characterization of the title compound are reported.

2. Results and Discussion

Our initial plan was to introduce a bromo group at the 2-methyl position of 7-methoxy-2,5-dimethyl-4-oxo-4H-chromene-3-carbaldehyde (1) [9] through deprotonative bromination. Compound 1 was treated with LiHMDS in THF at −78 °C for 10 minutes under an argon atmosphere, and the resulting reactive species was quenched with a THF solution of tetrabromomethane. As shown in Scheme 1, (Z)-2-(bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone (2), instead of 3, was obtained in good yield.
The structure of 2 was unambiguously assigned based on X-ray crystallography analysis (Figure 1), indicating that a bromo and a tribromomethyl group were installed at 2-methyl and C2 of the chromanone core, respectively. We presumed that the overall transformation commenced with a distal bromination of the deprotonated chromenone with CBr4, giving the brominated chromenone 3 and a tribromomethyl anion; the tribromomethyl anion counterattacked the β-carbon of compound 3 through a Michael reaction [10] to furnish the title compound. This result showcases an unusual reactivity mode for CBr4 and provides new insight into the halogenation chemistry of chromenone-based substrates.

3. Materials and Methods

3.1. General Experimental Information

The reaction was carried out with flame-dried glassware under an Ar atmosphere with the Schlenk line technique. Tetrahydrofuran was purified using a commercial solvent purification system. Tetrabromomethane was purchased from a commercial source and used without further purification. The reaction was monitored by thin-layer chromatography (TLC) on silica gel 60 Å F254 plates and visualized with 254 nm UV and KMnO4 as a color development agent. The reaction residue was purified via flash column chromatography with silica gel (230–400 mesh). The melting point was uncorrected. 1H NMR (600 MHz) and 13CNMR (150 MHz) spectra were recorded at 25 °C in CDCl3. Chemical shifts are reported in ppm to the high frequency of the reference, and coupling constants J are reported in Hz. High-resolution mass spectroscopy (HRMS) was performed on a TOF instrument with ESI in positive ionization mode.

3.2. Preparation of the Title Compound

A 50 mL round-bottom flask equipped with a magnetic stir bar was charged with 7-methoxy-2,5-dimethyl-4-oxo-4H-chromene-3-carbaldehyde (325 mg, 1.4 mmol, 1 equiv.), LiHMDS (1.0 M solution in toluene) (1.4 mL, 1.4 mmol, 1.0 equiv.) and THF (10.0 mL) under argon at −78 °C. After 10 minutes, a solution of CBr4 (465 mg, 1.4 mmol, 1.0 equiv.) in THF (5.0 mL) was added, and the mixture was stirred at the same temperature for 12 h. After the starting material was consumed as judged by TLC analysis; 2.0 N HCl(aq) (2 mL) was added dropwise to quench the reaction. The mixture was transferred to a separatory funnel, and the aqueous layer was extracted with EtOAc (3 × 30 mL). The combined organic layers were sequentially washed with water (30 mL) and brine (30 mL), dried over anhydrous Na2SO4, and filtered. The mixture was concentrated in vacuo and purified through flash column chromatography (Rf 0.8; n-hexane/EtOAc = 3:1), to give the chromanone compound (679 mg, 1.2 mmol, 86% yield) as a brown solid. Note: X-ray quality crystals were grown by the slow evaporation of a dichloromethane–methanol (v/v = 1:1) solution of 2. m.p. 67–68 °C. 1H NMR (600 MHz, CDCl3) δ 8.71 (d, J = 5.4 Hz, 1H), 6.41 (m, 2H), 4.45 (d, J = 11.4 Hz, 1H), 4.22 (d, J = 11.4 Hz, 1H), 3.85 (s, 3H), 2.65 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 181.3, 181.1, 165.1, 161.1, 143.2, 113.5, 108.9, 100.0, 98.8, 88.3, 55.6, 54.8, 35.6, 23.4. HRMS (ESI, [M+H]+) m/z (%) Calcd. for C14H12Br4O4 560.7547, found 560.7548.

3.3. X-Ray Structure Determination

X-ray diffraction data were collected at 200(2) K using a Bruker D8 Venture Dual Single Crystal X-ray Diffractometer in NTNU. Crystal data for C14H12Br4O4, M = 563.88 g mol−1, space group P 21/n, a = 8.3907(9) Å, b = 19.815(2) Å, c = 9.7637(12) Å, β = 94.456(4), V = 1618.5(3) Å3, Z = 4, Dcalc = 2.314 g∙cm−3. The final R1 [I > 2σ(I)] was 0.0567 and wR2 (all data) was 0.1486, with a goodness of fit on F2 of 1.027. Data have been deposited at the Cambridge Crystallographic Data Centre as CCDC 2445640. The data can be obtained free of charge from the Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/structures, accessed on 11 June 2025.

4. Conclusions

In summary, we present the vicinal bromo-tribromomethylation reaction of a 2-methyl-3-formyl-chromenone under basic conditions. Tetrabromomethane served as a novel counterattack reagent [11] for preparing a polybrominated heterocyclic framework.

Supplementary Materials

Copies of the 1H- and 13C-NMR spectra. A high-resolution mass spectrometry (HRMS) spectrum.

Author Contributions

Conceptualization, C.-C.L. and Y.-K.W.; methodology, C.-C.L.; validation, C.-C.L.; formal analysis, C.-C.L.; investigation, C.-C.L.; resources, C.-C.L.; data curation, C.-C.L.; writing—original draft preparation, C.-C.L.; writing—review and editing, Y.-K.W.; supervision, Y.-K.W.; project administration, Y.-K.W.; funding acquisition, Y.-K.W. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Ministry of Science and Technology in Taiwan, grant number NSTC 112-2628-M-A49-004-MY3.

Data Availability Statement

Data are contained within the article or Supplementary Materials.

Acknowledgments

We acknowledge Ting-Shen Kuo (NTNU Instrumentation Center) for support with X-ray crystallographic analysis. We thank Li-Ching Shen and You-Song Cheng (NYCU Instrumentation Resource Center) for their assistance with NMR experiments.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wilcken, R.; Zimmermann, M.O.; Lange, A.; Joerger, A.C.; Boeckler, F.M. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J. Med. Chem. 2013, 56, 1363–1388. [Google Scholar] [CrossRef] [PubMed]
  2. Saikia, I.; Borah, A.J.; Phukan, P. Use of Bromine and Bromo-Organic Compounds in Organic Synthesis. Chem. Rev. 2016, 116, 6837–7042. [Google Scholar] [CrossRef] [PubMed]
  3. Méndez, L.; Salazar, M.O.; Ramallo, I.A.; Furlan, R.L.E. Brominated Extracts as Source of Bioactive Compounds. ACS Comb. Sci. 2011, 13, 200–204. [Google Scholar] [CrossRef] [PubMed]
  4. Voskressensky, L.G.; Golantsova, N.E.; Maharramov, A.M. Recent Advances in Bromination of Aromatic and Heteroaromatic Compounds. Synthesis 2016, 48, 615–643. [Google Scholar] [CrossRef]
  5. Kumar, S.; Shah, T.A.; Punniyamurthy, T. Recent Advances in the Application of Tetrabromomethane in Organic Synthesis. Org. Chem. Front. 2021, 8, 4288–4313. [Google Scholar] [CrossRef]
  6. Bringmann, G.; Feineis, D.; Brückner, R.; Blank, M.; Peters, K.; Peters, E.-M.; Reichmann, H.; Janetzky, B.; Grote, C.; Clement, H.-W.; et al. Bromal-Derived Tetrahydro-β-carbolines as Neurotoxic Agents: Chemistry, Impairment of Dopamine Metabolism, and Inhibitory Effects on Mitochondrial Respiration. Bioorg. Med. Chem. 2000, 8, 1467–1478. [Google Scholar] [CrossRef] [PubMed]
  7. Li, Y.; Zhang, S.; Ding, H.; Sun, Z.; Ma, Q.; Yuan, Y.; Jia, X. Halogen Bond (XB) Promoted α-Tribromomethylation of N-Aryltetrahydroisoquinolines and Further Cyclization to 5,6-Dihydroindolo[2,1-a]isoquinolines. J. Org. Chem. 2023, 88, 11310–11321. [Google Scholar] [CrossRef] [PubMed]
  8. Zhang, Y.; Chen, C.; Zhao, J.; Liu, G. Rhodium-Catalyzed Cascade Radical Cyclization of 1,6-Enynes with Br–CX3: Access to Bromine-Containing Trihalomethylated Pyrrolidines. Asian J. Org. Chem. 2019, 8, 2249–2256. [Google Scholar] [CrossRef]
  9. Lee, C.-C.; Shia, K.-S.; Wu, Y.-K. Direct β-Methylation of α-Activated Cross-Conjugated Cycloalkenone Systems: Total Synthesis of Benastatins B and D and Me-oxo-pre-bikaverin. In Proceedings of the 7th NYCU-Gakushuin Student Symposium, Hsinchu, Taiwan, 2–3 November 2024; Abstract O-20. National Yang Ming Chiao Tung University: Hsinchu, Taiwan, 2024. [Google Scholar]
  10. Baird, M.S.; Buxton, S.R.; Sadler, P. Phase-Transfer Catalysed Reactions of Bromoform with Activated Alkenes: Evidence for a Tribromomethyl Anion Pathway. Tetrahedron Lett. 1985, 26, 6353–6356. [Google Scholar] [CrossRef]
  11. Hwu, J.R.; Gilbert, B.A. Counterattack Reagents in Organic Reactions and in Syntheses. Tetrahedron 1989, 45, 1233–1261. [Google Scholar] [CrossRef]
Scheme 1. Base-promoted Bromo-tribromomethylation of the chromenone.
Scheme 1. Base-promoted Bromo-tribromomethylation of the chromenone.
Molbank 2025 m2023 sch001
Figure 1. Labeled, 50%-probability, ellipsoid plot of the formula unit of (Z)-2-(bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone (CCDC 2445640).
Figure 1. Labeled, 50%-probability, ellipsoid plot of the formula unit of (Z)-2-(bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone (CCDC 2445640).
Molbank 2025 m2023 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lee, C.-C.; Wu, Y.-K. (Z)-2-(Bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone. Molbank 2025, 2025, M2023. https://doi.org/10.3390/M2023

AMA Style

Lee C-C, Wu Y-K. (Z)-2-(Bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone. Molbank. 2025; 2025(2):M2023. https://doi.org/10.3390/M2023

Chicago/Turabian Style

Lee, Chein-Chung, and Yen-Ku Wu. 2025. "(Z)-2-(Bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone" Molbank 2025, no. 2: M2023. https://doi.org/10.3390/M2023

APA Style

Lee, C.-C., & Wu, Y.-K. (2025). (Z)-2-(Bromomethyl)-3-(hydroxymethylene)-7-methoxy-5-methyl-2-(tribromomethyl)-4-chromanone. Molbank, 2025(2), M2023. https://doi.org/10.3390/M2023

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop